The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide Law: A Healthcare Attorney's Guide to the FD&C Act and Unapproved Drugs Holt Law The Amino zing World of Peptide Regulation ArentFox Schiff FDA Peptide Reclassification 2026: What It Means for Providers